Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International journal of pharmaceutics

• Publication date

  2005-03-23

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.IJPHARM.2004.11.031PMID 15725561
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats.

  2004cited by this paper
• Quercetin not only inhibits P-glycoprotein efflux activity but also inhibits CYP3A isozymes

  2004cited by this paper
• Quercetin potentiates the effect of adriamycin in a multidrug-resistant MCF-7 human breast-cancer cell line: P-glycoprotein as a possible target

  2004cited by this paper
• Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin.

  2004cited by this paper
• Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin.

  2003cited by this paper
• Polymer-modification of an anti-cancer drug: Effects on hydrodynamic properties

  2003cited by this paper
• Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450.

  2002cited by this paper
• Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel.

  2001cited by this paper
• Role of plant polyphenols in genomic stability.

  2001cited by this paper
• Bioflavonoids: selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1.

  2000cited by this paper
• Increased oral bioavailability of paclitaxel by GF120918 in mice through selective modulation of P-glycoprotein.

  2000cited by this paper
• Cytotoxic mechanism of flavonoid from Temu Kunci (Kaempferia pandurata) in cell culture of human mammary carcinoma

  2000cited by this paper
• Effect of the Grapefruit Flavonoid Naringin on Pharmacokinetics of Quinine in Rats

  2000cited by this paper
• Rapid and sensitive determination of paclitaxel in mouse plasma by high-performance liquid chromatography.

  1999cited by this paper
• Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein.

  1998cited by this paper
• Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.

  1998cited by this paper
• Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine.

  1997cited by this paper
• Taxol metabolism and disposition in cancer patients.

  1995cited by this paper
• Variability in human cytochrome P450 paclitaxel metabolism.

  1995cited by this paper
• Cytochrome P450 3A-mediated human liver microsomal taxol 6 alpha-hydroxylation.

  1994cited by this paper
• Selective biotransformation of taxol to 6 alpha-hydroxytaxol by human cytochrome P450 2C8.

  1994cited by this paper
• [Pharmacokinetics of paclitaxel in experimental animals. Part 2. Tissue distribution].

  1994cited by this paper
• Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation.

  1994cited by this paper
• [Determination of new anticancer drug, paclitaxel, in biological fluids by high performance liquid chromatography].

  1994cited by this paper
• Grapefruit juice–felodipine interaction: Mechanism, predictability, and effect of naringin

  1993cited by this paper
• Clinical toxicities encountered with paclitaxel (Taxol).

  1993cited by this paper
• Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer.

  1992cited by this paper
• Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

  1991cited by this paper
• A phase I trial of taxol given by a 6-hour intravenous infusion.

  1991cited by this paper
• Taxol: A unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms

  1990cited by this paper
• Taxol: a novel investigational antimicrotubule agent.

  1990cited by this paper
• Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.

  1989cited by this paper
• Phase I clinical and pharmacokinetic study of taxol.

  1987cited by this paper
• Taxol: an antimitotic agent with a new mechanism of action.

  1984cited by this paper
• Taxol-induced polymerization of purified tubulin. Mechanism of action.

  1981cited by this paper
• A pharmacokinetic analysis program (multi) for microcomputer.

  1981cited by this paper
• Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia.

  1971cited by this paper
• Cancer Research

  1965cited by this paper

• Strategies to Enhance the Bioavailability of Hydrophilic Drugs Using Natural Bioenhancers

  2025cites this paper
• Paclitaxel anti-cancer therapeutics: from discovery to clinical use.

  2025cites this paper
• Formulation and Evaluation of Raloxifene Hydrochloride Co-Crystals with Bioenhancer – a Potential Approach for Solubility and Bioavailability Enhancement

  2025cites this paper
• Flavonoids as Bioenhancers: A Critical Review on Their Potential to Improve Drug Delivery and Therapeutic Outcomes

  2025cites this paper
• Paclitaxel and its semi-synthetic derivatives: comprehensive insights into chemical structure, mechanisms of action, and anticancer properties

  2024cites this paper
• Co-Delivery of Naringin and Ciprofloxacin by Oleic Acid Lipid Core Encapsulated in Carboxymethyl Chitosan/Alginate Nanoparticle Composite for Enhanced Antimicrobial Activity

  2024cites this paper
• Optimizing Paclitaxel Oral Absorption and Bioavailability: TPGS Co-Coating via Supercritical Anti-Solvent Fluidized Bed Technology

  2024cites this paper
• Tailoring Deep Eutectic Solvents to Provoke Solubility and Bioavailability of Naringin: Implications of a Computational Approach

  2023cites this paper
• Natural biomass-derived carbon dots as a potent solubilizer with high biocompatibility and enhanced antioxidant activity

  2023cites this paper
• Research progress on the anti-tumor effect of Naringin

  2023cites this paper
• Biological Activities and Solubilization Methodologies of Naringin

  2023cites this paper
• Interactions of bioflavonoids and other polyphenolic-type nutraceuticals with drugs

  2022cites this paper
• The Potential Role of Naringin and Naringenin as Nutraceuticals against Metabolic Syndrome.

  2022cites this paper
• Effect of Naringin Co-administration on Oral Bioavailability of Efavirenz in Rabbit

  2022cites this paper
• Polyphenols: The interactions with CYP 450 isoenzymes and effect on pharmacokinetics of drugs

  2022cites this paper
• Oral Bioavailability Enhancement of Efavirenz using Piperine coadministration in Experimental Rabbits

  2022cites this paper
• Naringin: A potential natural product in the field of biomedical applications

  2021cites this paper
• Modifications of Plasma Membrane Organization in Cancer Cells for Targeted Therapy

  2021cites this paper
• Norcantharidin combined with paclitaxel induces endoplasmic reticulum stress mediated apoptotic effect in prostate cancer cells by targeting SIRT7 expression

  2021cites this paper
• Synthesis and characterization of paclitaxel nanoparticles for drug delivery

  2021cites this paper
• Flavonoid-Mediated Modulation of CYP3A Enzyme and P-Glycoprotein Transporter: Potential Effects on Bioavailability and Disposition of Tyrosine Kinase Inhibitors

  2020cites this paper
• The pharmacokinetics of flavanones

  2020cites this paper
• Naringin sensitizes the antibiofilm effect of ciprofloxacin and tetracycline against Pseudomonas aeruginosa biofilm.

  2020cites this paper
• Influence of quercetin and chrysin on the intestinal permeability of paclitaxel, a substrate of P-glycoprotein and CYP3A4 using in vitro rat gut sacs

  2019influential citation
• Drug Bioavailability Enhancing Agents of Natural Origin (Bioenhancers) that Modulate Drug Membrane Permeation and Pre-Systemic Metabolism

  2019cites this paper
• Bioenhancing effects of naringin on atorvastatin

  2019cites this paper
• Enhanced oral bioavailability of docetaxel in rats combined with myricetin: In situ and in vivo evidences

  2017cites this paper
• Naringin sensitizes human prostate cancer cells to paclitaxel therapy

  2017cites this paper
• A pre-formulation study of a polymeric solid dispersion of paclitaxel prepared using a quasi-emulsion solvent diffusion method to improve the oral bioavailability in rats

  2016cites this paper
• Effects of FUX on gemcitabine sensitivity in lung cancer cells

  2015cites this paper
• Inhalable, large porous PLGA microparticles loaded with paclitaxel: preparation, in vitro and in vivo characterization

  2015cites this paper
• Apical ABC transporters and cancer chemotherapeutic drug disposition.

  2015cites this paper
• Natural Bioenhancers: Current Outlook

  2015cites this paper
• Preparation and evaluation of PEGylated and folate-PEGylated liposomes containing paclitaxel for lymphatic delivery

  2015cites this paper
• Effects of FUX on gemcitabine sensitivity in lung cancer cells

  2015cites this paper
• Chapter 14 – Drugs That Modulate Resistance to Antitumor Agents

  2015cites this paper
• Taxane conjugate nanoparticles for improved non-small cell lung cancer treatment in a novel orthotopic mouse model

  2014cites this paper
• Role of herbal bioactives as a potential bioavailability enhancer for Active Pharmaceutical Ingredients.

  2014cites this paper
• Development and Validation of Liquid Chromatographic Method for Estimation of Naringin in Nanoformulation

  2014cites this paper
• Bioavailability of Flavonoids

  2014cites this paper
• Pharmacokinetic drug interactions between apigenin, rutin and paclitaxel mediated by P-glycoprotein in rats

  2014cites this paper
• The effects of flavonoids on the ABC transporters: consequences for the pharmacokinetics of substrate drugs

  2013cites this paper
• Development and clinical application of oral dosage forms of taxanes

  2013cites this paper
• Flavonoids and Drug Interactions

  2012cites this paper
• Overview of P-glycoprotein inhibitors: a rational outlook

  2012cites this paper
• Studies on some absorption promoters of Herbal Origin

  2011cites this paper
• Double directional adjusting estrogenic effect of naringin from Rhizoma drynariae (Gusuibu).

  2011cites this paper
• Herbal Supplement-Based Interactions

  2010cites this paper
• Enhanced oral bioavailability of paclitaxel formulated in vitamin E-TPGS emulsified nanoparticles of biodegradable polymers: in vitro and in vivo studies.

  2010cites this paper
• Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N, O-hydroxyethyl chitosan micellar system.

  2010cites this paper
• Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response.

  2010cites this paper
• The Promotive Effects of Antioxidative Apigenin on the Bioavailability of Paclitaxel for Oral Delivery in Rats

  2010cites this paper
• Effects of Silibinin, Inhibitor of CYP3A4 and P-Glycoprotein in vitro, on the Pharmacokinetics of Paclitaxel after Oral and Intravenous Administration in Rats

  2010cites this paper
• PEG–Anticancer Drugs

  2010cites this paper
• Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats.

  2010cites this paper
• Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer

  2010cites this paper
• Polymer prodrug approaches applied to paclitaxel

  2010cites this paper
• Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy.

  2009cites this paper
• The Pharmacological Actions of Grapefruit Extracts: Naringin and Naringinin

  2009cites this paper
• Paclitaxel-containing nano-engineered polymeric capsules towards cancer therapy.

  2009cites this paper
• Conjugated chitosan as a novel platform for oral delivery of paclitaxel.

  2008cites this paper
• Effects of Naringin on the Bioavailability of Nimodipine in Rabbits

  2008cites this paper
• Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: possible contribution of P-glycoprotein.

  2008cites this paper
• Effects of Naringin on the Bioavailability of Etoposide in Rats

  2008cites this paper
• Drugs That Modulate Resistance to Antitumor Agents

  2008cites this paper
• The potential of flavonoids to influence drug metabolism and pharmacokinetics by local gastrointestinal mechanisms.

  2006cites this paper
• Development of a piezoelectric immunosensor for the measurement of paclitaxel.

  2006cites this paper
• Paclitaxel prodrugs: toward smarter delivery of anticancer agents.

  2006cites this paper
• Effects of morin pretreatment on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem in rats

  2005cites this paper
• Effects of morin pretreatment on the pharmacokinetics of diltiazem and its major metabolite, desacetyldiltiazem in rats

  2005cites this paper
• Enhanced oral exposure of diltiazem by the concomitant use of naringin in rats.

  2005cites this paper
• Molecular mechanisms of the naringin low uptake by intestinal Caco-2 cells.

  2005cites this paper